* Clover Health Investments Corp CLOV.OQ reported a
quarterly
adjusted loss of 4 cents per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -15 cents. The mean expectation of
three analysts for the quarter was for a loss of 7 cents per
share. Wall Street expected results to range from -9 cents to -6
cents per share.
* Revenue fell 34.3% to $346.92 million from a year ago;
analysts
expected $321.23 million.
* Clover Health Investments Corp's reported EPS for the
quarter
was a loss of 4 cents.
* The company reported a quarterly loss of $19.17 million.
* Clover Health Investments Corp shares had fallen by 6.8%
this
quarter and lost 22.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 4% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the managed
healthcare
peer group is also "hold"
Wall Street's median 12-month price target for Clover Health
Investments Corp is $1.38
This summary was machine generated from LSEG data May 8 at 11:40
a.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.07 -0.04 Beat
Dec. 31 2023 -0.14 -0.14 Met
Sep. 30 2023 -0.11 -0.09 Beat
Jun. 30 2023 -0.15 -0.06 Beat